Janux Therapeutics, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-12-31

Reported

2026-02-26

Disclosure lag

57 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Janux Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001817713/2026-07-26
Event ID	#29432

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001193125-26-076918",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "FY",
  "fiscal_year": 2025,
  "form": "10-K",
  "mapped_tag_share": 0.05963302752293578,
  "metrics": {
    "cash_and_equivalents": 52334000,
    "earnings_per_share_basic": -1.83,
    "earnings_per_share_diluted": -1.83,
    "net_income": -113625000,
    "operating_cash_flow": -82235000,
    "operating_income": -157667000,
    "revenue": 10000000,
    "shareholders_equity": 956822000,
    "shares_outstanding": 60384283,
    "total_assets": 1001565000,
    "total_liabilities": 44743000
  },
  "metrics_reported": 11,
  "period_end": "2025-12-31"
}

Source: SEC EDGAR · as of 2026-02-26T00:00:00Z